LEI 213800NECEZ2CC2BOR25

UCB PHARMA

Group parent: U C B

Awards tracked

19

Value

€5.23M

Countries

ES, BE

Download sample CSV

Contract awards & public grants

Spain – Pharmaceutical products – JAEN CBAM UCB PHARMA. S.A. AM 578/2025 → UCB PHARMA S.A.

Servicio Andaluz de Salud. Hospital Universitario de Jaén · ES · Tender · 2026-08-20

€330,165

MOlecular BIodiscovery for Life sciences InTerdiscplinarY innovation → UCB PHARMA SA

European Commission · BE · Grant · 2026-07-02

—

Improving Drug Efficacy with next-generation AmorphouS materials and trained experts → UCB PHARMA SA

European Commission · BE · Grant · 2026-06-25

—

Spain – Various medicinal products – Suministro de los productos farmacéuticos Fruquintinib y Fenfluramina para el Complejo Hospitalario Uni → UCB PHARMA, S.A.

Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil · ES · Tender · 2026-06-19

€63,804

Spain – Pharmaceutical products – HUELVA 1º CBAM AM 2204/2025 (Nº SIGLO 578/2025 ;CCA:+6.I+E9Q8J) → UCB PHARMA S.A.

Servicio Andaluz de Salud. Hospital Universitario Juan Ramón Jiménez · ES · Tender · 2026-06-17

€307,259

FORTIFY - FRAMEWORK FOR OPTIMIZED REGULATION, TRADE SECRETS, AND INTELLECTUAL PROPERTY IN A FEDERATED EUROPEAN HEALTH DATA SPACE → UCB PHARMA SA

European Commission · BE · Grant · 2026-06-02

—

Spain – Pharmaceutical products – Suministro de Fenfluramina (DOE) y Bimekizumab (DOE) → UCB PHARMA, S.A.

OSAKIDETZA - Servicio Vasco de Salud - Organización Central · ES · Tender · 2026-06-02

€228,350

Spain – Various medicinal products – Adjudicación del Contrato Específico del Medicamento BIMEKIZUMAB, derivado del Sistema Dinámico de Adqu → UCB PHARMA, S.A.

Badalona Serveis Assistencials, SA. · ES · Tender · 2026-05-29

€261,119

Spain – Various medicinal products – Adjudicación del Contrato Específico del Medicamento BIMEKIZUMAB, derivado del Sistema Dinámico de Adqu → UCB PHARMA, S.A.

Gestió Pius Hospital de Valls, SAM · ES · Tender · 2026-05-29

€923,241

Spain – Pharmaceutical products – Adjudicación del Contrato Específico del Medicamento BIMEKIZUMAB, derivado del Sistema Dinámico de Adquisi → UCB PHARMA, S.A.

Consorci Sanitari Integral · ES · Tender · 2026-05-29

€1.89M

Spain – Pharmaceutical products – CONTR 2026 200963 CBAM-1 GRANADA AMC 2204-2025 (578/2025) MEDICAMENTOS EXCLUSIVOS → UCB PHARMA S.A.

Servicio Andaluz de Salud. Hospital Universitario Virgen de las Nieves · ES · Tender · 2026-05-28

€687,398

Spain – Pharmaceutical products – JAEN CBAM UCB PHARMA, S.A. AM 1108/2023 → UCB PHARMA, S.A.

Servicio Andaluz de Salud. Hospital Universitario de Jaén · ES · Tender · 2024-08-29

€291,690

Advanced Multiscale Biological Imaging using European Infrastructures → UCB PHARMA SA

European Commission · BE · Grant · 2023-10-17

—

The GEne Therapy INnovation Training Network → UCB PHARMA SA

European Commission · BE · Grant · 2023-07-05

—

A new generation of microbial expression hosts and tools for the production of biotherapeutics and high-value enzymes → UCB PHARMA SA

European Commission · BE · Grant · 2018-08-30

—

ISOTOPIC LABELING FOR DRUG INNOVATION → UCB PHARMA SA

European Commission · BE · Grant · 2015-08-10

—

European Vascular Interventions and Therapeutic Innovation Network → UCB PHARMA SA

European Commission · BE · Grant · 2015-08-07

—

Engineering of new-generation protein secretion systems → UCB PHARMA SA

European Commission · BE · Grant · 2014-12-10

—

Enhancing CHO by Mammalian Systems Biotechnology (eCHO systems) → UCB PHARMA SA

European Commission · BE · Grant · 2014-12-05

€250,560

Entity identity is matched from published recipient names and registry IDs to GLEIF legal-entity records; matches can be imperfect. Source records are public procurement and grant notices.